Position in GRAL
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$583,435
+$141,778 QoQ
Shares Held
8,546
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#141
of 371 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SHEETS SMITH WEALTH MANAGEMENT holds $13,376,260 across 7 Diagnostics & Research names. GRAL ranks #4 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
38,080 | $7,357,817 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
5,200 | $2,607,072 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
2,962 | $1,568,645 | |
| 4 | GRAL |
GRAIL, Inc.
This page
|
8,546 | $583,435 | |
| 5 | WAT |
Waters Corp /De/
|
1,431 | $536,682 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,667 | $466,760 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
486 | $255,849 |
All Filings in GRAL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $583,435 | 8,546 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $441,657 | 8,546 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $733,078 | 8,565 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $512,065 | 8,660 | Shares | Sole | 2025-10-16 | |
| No filing history on record for this holder in this stock. | ||||||